RadioMedix Competitors and Similar CompaniesClear all

RadioMedix's competitors and similar companies include Alzeca Biosciences, BiBBInstruments, Cyclomics, Imaqen and Exosomics.
RadioMedix
RadioMedix
RadioMedix is a biotechnology company focused on providing targeted radiopharmaceuticals for diagnosis, monitoring, and therapy of cancer.
Alzeca Biosciences
Alzeca Biosciences
Alzeca Biosciences is a company developing imaging technologies.
BiBBInstruments
BiBBInstruments
BiBBInstruments (BiBB) is a medtech company that develops and markets diagnostic instruments under the brand name EndoDrill.
Cyclomics
Cyclomics
Cyclomics is a company engaged in cancer diagnostics and treatment monitoring.
Imaqen
Imaqen
Imaqen is a healthcare technology company developing a pre-screening solution for early detection of cancer.
Exosomics
Exosomics
Exosomics is a company specializing in cancer diagnostics.
Founding Date
Founding Date
2006
Founding Date
2012
Founding Date
2013
Founding Date
2018
Founding Date
2016
Founding Date
2011
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Houston, US HQ
Humble, US
Locations
Houston, US HQ
Locations
Lund, SE HQ
Locations
Utrecht, NL HQ
Locations
Helsinki, FI HQ
Turku, FI
Locations
Siena, IT HQ
Employees
Employees
386% increase
Employees
5
Employees
10
Employees
10
Employees
10
Employees
5
For sources of this data, please see the company profile

View Company Profiles

Alzeca Biosciences
HQ
Houston, US
Employees
5

Alzeca Biosciences is a company developing imaging technologies.

View company
BiBBInstruments
HQ
Lund, SE
Employees
10

BiBBInstruments (BiBB) is a medtech company that develops and markets diagnostic instruments under the brand name EndoDrill.

View company
Cyclomics
HQ
Utrecht, NL
Employees
10

Cyclomics is a company engaged in cancer diagnostics and treatment monitoring.

View company
Imaqen
HQ
Helsinki, FI
Employees
10

Imaqen is a healthcare technology company developing a pre-screening solution for early detection of cancer.

View company